Evidence map›Paper›PMID 32463181›Full record

ArticleNeuropsychopharmacology reports2020

Dietary intake of glucoraphanin during pregnancy and lactation prevents the behavioral abnormalities in the offspring after maternal immune activation.

Yuko Fujita, Atsuhiro Fujita, Tamaki Ishima, Ayumi Hirai, Shigenori Suzuki, Hiroyuki Suganuma, Kenji Hashimoto

Open access · goldAbstract read
In one paragraph

Article in Neuropsychopharmacology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Frontiers in microbiology · 2023
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Preventive psychiatry: a blueprint for improving the mental health of young people.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2021
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yuko FujitaDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Atsuhiro FujitaDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Tamaki IshimaDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
Ayumi HiraiInnovation Division, Kagome Co., Ltd., Nasushiobara, Japan.
Shigenori SuzukiInnovation Division, Kagome Co., Ltd., Nasushiobara, Japan.
Hiroyuki SuganumaInnovation Division, Kagome Co., Ltd., Nasushiobara, Japan.
Kenji HashimotoDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.ORCID 0000-0002-8892-0439
Center for Forensic Mental Health, Chiba University · JPEbara (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimEpidemiological data suggest that maternal immune activation (MIA) plays a role in the etiology of neuropsychiatric disorders including autism spectrum disorder (ASD) and schizophrenia. However, there is no prophylactic nutrition that can prevent the onset of neurodevelopmental disorders in offspring after MIA. The aim of this study was undertaken to examine whether dietary intake of glucoraphanin (GF: the precursor of a natural anti-inflammatory compound sulforaphane) can prevent the onset of behavioral abnormalities in offspring after MIA.

methodsOne percent of GF food pellet or normal food pellet was given into female mice during pregnancy and lactation (from E5 to P21). Saline (5 mL/kg/d) or poly(I:C) (5 mg/kg/d) was injected into pregnant mice from E12 to E17. Behavioral tests and immunohistochemistry of parvalbumin (PV) were performed in male offspring.

resultsDietary intake of GF during pregnancy and lactation prevented cognitive deficits and social interaction deficits in the juvenile offspring after MIA. Furthermore, dietary intake of GF during pregnancy and lactation prevented cognitive deficits in the adult offspring after MIA. Moreover, dietary intake of GF prevented the reduction of PV immunoreactivity in the medial prefrontal cortex of adult offspring after MIA.

conclusionThese data suggest that dietary intake of GF during pregnancy and lactation could prevent behavioral abnormalities in offspring after MIA.

Indexed as

AnimalsCognitionFemaleGlucosinolatesLactationMaleMiceNeurodevelopmental DisordersOximesPregnancyPrenatal Exposure Delayed EffectsSulfoxidesglucoraphaninGlucosinolatesOximesSulfoxidesautismglucoraphaninnutritionpreventionschizophreniasulforaphane

Identifiers

PMID32463181
PMCPMC7722647
OpenAlexW3030085460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.